Neuroscience of fear extinction: Implications for assessment and treatment of fear-based and anxiety related disorders

Behaviour Research and Therapy

Volumn 62, Issue , 2014, Pages 17-23

  Milad, Mohammed R ^a   Rosenbaum, Blake L ^a   Simon, Naomi M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Amygdala; DCS; Exposure therapy; Fear conditioning; VmPFC; Yohimbine

Indexed keywords

CYCLOSERINE; METHYLENE BLUE; PLACEBO; YOHIMBINE;

ACROPHOBIA; ANXIETY DISORDER; ARTICLE; BEHAVIOR THERAPY; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; BRAIN REGION; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; CONDITIONING; DRUG MECHANISM; EXPOSURE THERAPY; FEAR; FEAR EXTINCTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MULTICENTER STUDY (TOPIC); NERVE CELL NETWORK; NEUROSCIENCE; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; OPTOGENETICS; PHOBIA; POSITRON EMISSION TOMOGRAPHY; POSTTRAUMATIC STRESS DISORDER; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL PHOBIA; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; TRANSLATIONAL RESEARCH; ANXIETY; ANXIETY DISORDERS; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; PSYCHOTHERAPY; REINFORCEMENT;

ANXIETY; ANXIETY DISORDERS; CONDITIONING (PSYCHOLOGY); EXTINCTION, PSYCHOLOGICAL; FEAR; HUMANS; PSYCHOTHERAPY;

EID: 84910038002     PISSN: 00057967     EISSN: 1873622X     Source Type: Journal    
DOI: 10.1016/j.brat.2014.08.006     Document Type: Article

References (100)

1. Adamantidis A.R., Zhang F., de Lecea L., Deisseroth K. Optogenetics: opsins and optical interfaces in neuroscience. Cold Spring Harbor Protocols 2014, 2014(8). pdb top.083329. 10.1101/pdb.top083329.
2. Asami T., Hayano F., Nakamura M., Yamasue H., Uehara K., Otsuka T., et al. Anterior cingulate cortex volume reduction in patients with panic disorder. Psychiatry and Clinical Neurosciences 2008, 62(3):322-330. PCN1800 [pii]. 10.1111/j.1440-1819.2008.01800.x.
3. Association A.P. Diagnostic and statistical manual of mental disorders 2013, American Psychiatric Publishing, Arlington, VA. 5th ed.
4. Blechert J., Michael T., Vriends N., Margraf J., Wilhelm F.H. Fear conditioning in posttraumatic stress disorder: evidence for delayed extinction of autonomic, experiential, and behavioural responses. Behaviour Research and Therapy 2007 Sep, 45(9):2019-2033. Epub 2007 Mar 12.
5. Bouton M.E. Context, ambiguity, and unlearning: sources of relapse after behavioral extinction. Biological Psychiatry 2002, 52(10):976-986.
6. Bouton M.E., Moody E.W. Memory processes in classical conditioning. Neuroscience and Biobehavioral Reviews 2004, 28(7):663-674. 10.1016/j.neubiorev.2004.09.001.
7. Bouton M.E., Vurbic D., Woods A.M. D-cycloserine facilitates context-specific fear extinction learning. Neurobiology of Learning and Memory 2008, 90(3):504-510. 10.1016/j.nlm.2008.07.003.
8. Boyden E.S., Zhang F., Bamberg E., Nagel G., Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nature Neuroscience 2005, 8(9):1263-1268. 10.1038/nn1525.
9. Breier A., Charney D.S., Heninger G.R. Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness. Archives of General Psychiatry 1986, 43(11):1029-1036.
10. Bremner J.D., Vermetten E., Schmahl C., Vaccarino V., Vythilingam M., Afzal N., et al. Positron emission tomographic imaging of neural correlates of a fear acquisition and extinction paradigm in women with childhood sexual-abuse-related post-traumatic stress disorder. Psychological Medicine 2005, 35(6):791-806.
11. Bryant R.A., Felmingham K., Kemp A.H., Das P., Hughes G., Peduto A., et al. Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder. Psychological Medicine 2008, 38(4):555-561.
12. Buhlmann U., Wilhelm S., Deckersbach T., Rauch S.L., Pitman R.K., Orr S.P. Physiologic responses to loud tones in individuals with obsessive-compulsive disorder. Psychosomatic Medicine 2007, 69(2):166-172. 10.1097/PSY.0b013e31802f2799.
13. Burgos-Robles A., Vidal-Gonzalez I., Quirk G.J. Sustained conditioned responses in prelimbic prefrontal neurons are correlated with fear expression and extinction failure. The Journal of Neuroscience 2009, 29(26):8474-8482.
14. Burgos-Robles A., Vidal-Gonzalez I., Santini E., Quirk G.J. Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron 2007, 53(6):871-880.
15. Carson M.A., Metzger L.J., Lasko N.B., Paulus L.A., Morse A.E., Pitman R.K., et al. Physiologic reactivity to startling tones in female Vietnam nurse veterans with PTSD. Journal of Traumatic Stress 2007, 20(5):657-666. 10.1002/jts.20218.
16. Chang Y.J., Yang C.H., Liang Y.C., Yeh C.M., Huang C.C., Hsu K.S. Estrogen modulates sexually dimorphic contextual fear extinction in rats through estrogen receptor beta. Hippocampus 2009 Nov, 19(11):1142-1150. 10.1002/hipo.20581.
17. Ciocchi S., Herry C., Grenier F., Wolff S.B., Letzkus J.J., Vlachos I., et al. Encoding of conditioned fear in central amygdala inhibitory circuits. Nature 2010, 468(7321):277-282. 10.1038/nature09559.
18. Corcoran K.A., Quirk G.J. Recalling safety: cooperative functions of the ventromedial prefrontal cortex and the hippocampus in extinction. CNS Spectrums 2007, 12(3):200-206.
19. Davis M., Ressler K., Rothbaum B.O., Richardson R. Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biological Psychiatry 2006, 60(4):369-375. 10.1016/j.biopsych.2006.03.084.
20. de Kleine R.A., Hendriks G.J., Kusters W.J., Broekman T.G., van Minnen A. Arandomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biological Psychiatry 2012, 71(11):962-968. 10.1016/j.biopsych.2012.02.033.
21. Delgado M.R., Nearing K.I., Ledoux J.E., Phelps E.A. Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron 2008, 59(5):829-838.
22. Difede J., Cukor J., Wyka K., Olden M., Hoffman H., Lee F.S., et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology 2014, 39(5):1052-1058. 10.1038/npp.2013.317.
23. Duvarci S., Pare D. Amygdala microcircuits controlling learned fear. Neuron 2014, 82(5):966-980. 10.1016/j.neuron.2014.04.042.
24. Etkin A., Egner T., Kalisch R. Emotional processing in anterior cingulate and medial prefrontal cortex. Trends in Cognitive Sciences 2011, 15(2):85-93. S1364-6613(10)00252-4 [pii]. 10.1016/j.tics.2010.11.004.
25. Etkin A., Wager T.D. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. American Journal of Psychiatry 2007, 164(10):1476-1488.
26. Falconer E., Allen A., Felmingham K.L., Williams L.M., Bryant R.A. Inhibitory neural activity predicts response to cognitive-behavioral therapy for posttraumatic stress disorder. Journal of Clinical Psychiatry 2013, 74(9):895-901. 10.4088/JCP.12m08020.
27. Felmingham K.L., Dobson-Stone C., Schofield P.R., Quirk G.J., Bryant R.A. The brain-derived neurotrophic factor Val66Met polymorphism predicts response to exposure therapy in posttraumatic stress disorder. Biological Psychiatry 2013, 73(11):1059-1063. 10.1016/j.biopsych.2012.10.033.
28. Gonzalez-Lima F., Bruchey A.K. Extinction memory improvement by the metabolic enhancer methylene blue. Learning & Memory 2004, 11(5):633-640.
29. Graham B.M., Milad M.R. Blockade of estrogen by hormonal contraceptives impairs fear extinction in female rats and women. Biological Psychiatry 2013, 73(4):371-378. 10.1016/j.biopsych.2012.09.018.
30. Hart G., Panayi M.C., Harris J.A., Westbrook R.F. Benzodiazepine treatment can impair or spare extinction, depending on when it is given. Behaviour Research and Therapy 2014, 56:22-29. 10.1016/j.brat.2014.02.004.
31. Hartley C.A., Fischl B., Phelps E.A. Brain structure correlates of individual differences in the acquisition and inhibition of conditioned fear. Cerebral Cortex 2011, 21(9):1954-1962. bhq253 [pii]. 10.1093/cercor/bhq253.
32. Haubensak W., Kunwar P.S., Cai H., Ciocchi S., Wall N.R., Ponnusamy R., et al. Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature 2010, 468(7321):270-276. 10.1038/nature09553.
33. Hermann A., Schafer A., Walter B., Stark R., Vaitl D., Schienle A. Emotion regulation in spider phobia: role of the medial prefrontal cortex. Social Cognitive and Affective Neuroscience 2009, 4(3):257-267. nsp013 [pii]. 10.1093/scan/nsp013.
34. Hermann C., Ofer J., Flor H. Covariation bias for ambiguous social stimuli in generalized social phobia. Journal of Abnormal Psychology 2004, 113(4):646-653. 2004-20178-015 [pii]. 10.1037/0021-843X.113.4.646.
35. Hermans D., Craske M.G., Mineka S., Lovibond P.F. Extinction in human fear conditioning. Biological Psychiatry 2006, 60(4):361-368.
36. Herry C., Ferraguti F., Singewald N., Letzkus J.J., Ehrlich I., Luthi A. Neuronal circuits of fear extinction. European Journal of Neuroscience 2010, 31(4):599-612.
37. Hofmann S.G., Pollack M.H., Otto M.W. Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. CNS Drug Reviews 2006, 12(3-4):208-217. 10.1111/j.1527-3458.2006.00208.x.
38. Hofmann S.G., Smits J.A., Rosenfield D., Simon N., Otto M.W., Meuret A.E., et al. D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder. American Journal of Psychiatry 2013, 170(7):751-758. 10.1176/appi.ajp.2013.12070974.
39. Holmes A., Quirk G.J. Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders-the case of yohimbine. Trends in Pharmacological Sciences 2010, 31(1):2-7. 10.1016/j.tips.2009.10.003.
40. Johansen J.P., Hamanaka H., Monfils M.H., Behnia R., Deisseroth K., Blair H.T., et al. Optical activation of lateral amygdala pyramidal cells instructs associative fear learning. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(28):12692-12697. 10.1073/pnas.1002418107.
41. Jovanovic T., Norrholm S.D., Blanding N.Q., Davis M., Duncan E., Bradley B., et al. Impaired fear inhibition is a biomarker of PTSD but not depression. Depression and Anxiety 2010, 27(3):244-251.
42. Jovanovic T., Norrholm S.D., Fennell J.E., Keyes M., Fiallos A.M., Myers K.M., Duncan E.J. Posttraumatic stress disorder may be associated with impaired fear inhibition: relation to symptom severity. Psychiatry Research 2009, 167(1-2):151-160.
43. Kalisch R., Korenfeld E., Stephan K.E., Weiskopf N., Seymour B., Dolan R.J. Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network. The Journal of Neuroscience 2006, 26(37):9503-9511.
44. Kim M.J., Gee D.G., Loucks R.A., Davis F.C., Whalen P.J. Anxiety dissociates dorsal and ventral medial prefrontal cortex functional connectivity with the amygdala at rest. Cerebral Cortex 2011, 21(7):1667-1673. bhq237 [pii]. 10.1093/cercor/bhq237.
45. Kim M.J., Whalen P.J. The structural integrity of an amygdala-prefrontal pathway predicts trait anxiety. The Journal of Neuroscience 2009, 29(37):11614-11618. 29/37/11614 [pii]. 10.1523/JNEUROSCI.2335-09.2009.
46. Knight D.C., Smith C.N., Cheng D.T., Stein E.A., Helmstetter F.J. Amygdala and hippocampal activity during acquisition and extinction of human fear conditioning. Cognitive, Affective & Behavioral Neuroscience 2004, 4(3):317-325.
47. LaBar K.S., Gatenby J.C., Gore J.C., Ledoux J.E., Phelps E.A. Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 1998, 20(5):937-945.
48. Lebron-Milad K., Milad M.R. Sex differences, gonadal hormones and the fear extinction network: implications for anxiety disorders. Biology of Mood & Anxiety Disorders 2012, 2(1):3. 10.1186/2045-5380-2-3.
49. Ledoux J.E. Emotion circuits in the brain. Annual Review of Neuroscience 2000, 23:155-184.
50. Lee J.H., Kwon H., Choi J., Yang B.H. Cue-exposure therapy to decrease alcohol craving in virtual environment. Cyberpsychology & Behavior 2007, 10(5):617-623. 10.1089/cpb.2007.9978.
51. Linnman C., Rougemont-Bucking A., Beucke J.C., Zeffiro T.A., Milad M.R. Unconditioned responses and functional fear networks in human classical conditioning. Behavioural Brain Research 2011, 221(1):237-245. S0166-4328(11)00161-6 [pii]. 10.1016/j.bbr.2011.02.045.
52. Lissek S., Levenson J., Biggs A.L., Johnson L.L., Ameli R., Pine D.S., et al. Elevated fear conditioning to socially relevant unconditioned stimuli in social anxiety disorder. The American Journal of Psychiatry 2008, 165(1):124-132. appi.ajp.2007.06091513 [pii]. 10.1176/appi.ajp.2007.06091513.
53. Litz B.T., Salters-Pedneault K., Steenkamp M.M., Hermos J.A., Bryant R.A., Otto M.W., et al. Arandomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. Journal of Psychiatric Research 2012, 46(9):1184-1190. 10.1016/j.jpsychires.2012.05.006.
54. Lovibond P.F., Mitchell C.J., Minard E., Brady A., Menzies R.G. Safety behaviours preserve threat beliefs: Protection from extinction of human fear conditioning by an avoidance response. Behaviour Research and Therapy 2009, 47(8):716-720. 10.1016/j.brat.2009.04.013.
55. Lovibond P.F., Saunders J.C., Weidemann G., Mitchell C.J. Evidence for expectancy as a mediator of avoidance and anxiety in a laboratory model of human avoidance learning. The Quarterly Journal of Experimental Psychology (Hove) 2008, 61(8):1199-1216.
56. Maren S., Quirk G.J. Neuronal signalling of fear memory. Nature Reviews Neuroscience 2004, 5(11):844-852.
57. Marin M.F., Camprodon J.A., Dougherty D.D., Milad M.R. Device-based brain stimulation to augment fear extinction: implications for PTSD treatment and beyond. Depression and Anxiety 2014, 31(4):269-278. 10.1002/da.22252.
58. Mennin D.S., Heimberg R.G., Turk C.L., Fresco D.M. Preliminary evidence for an emotion dysregulation model of generalized anxiety disorder. Behaviour Research and Therapy 2005, 43(10):1281-1310. 10.1016/j.brat.2004.08.008.
59. Meyerbroeker K., Powers M.B., van Stegeren A., Emmelkamp P.M. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial. Psychotherapy and Psychosomatics 2012, 81(1):29-37. 10.1159/000329454.
60. Michael T., Blechert J., Vriends N., Margraf J., Wilhelm F.H. Fear conditioning in panic disorder: enhanced resistance to extinction. Journal of Abnormal Psychology 2007, 116(3):612-617. 2007-11737-018 [pii]. 10.1037/0021-843X.116.3.612.
61. Milad M.R., Furtak S.C., Greenberg J.L., Keshaviah A., Im J.J., Falkenstein M.J., et al. Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit. JAMA Psychiatry 2013, 70(6):608-618. quiz 554, 1679422 [pii]. 10.1001/jamapsychiatry.2013.914.
62. Milad M.R., Igoe S.A., Lebron-Milad K., Novales J.E. Estrous cycle phase and gonadal hormones influence conditioned fear extinction. Neuroscience 2009, 164(3):887-895. S0306-4522(09)01486-9 [pii]. 10.1016/j.neuroscience.2009.09.011.
63. Milad M.R., Orr S.P., Lasko N.B., Chang Y., Rauch S.L., Pitman R.K. Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. Journal of Psychiatric Research 2008 Jun, 42(7):515-520. Epub 2008 Feb 29. 10.1016/j.jpsychires.2008.01.017.
64. Milad M.R., Pitman R.K., Ellis C.B., Gold A.B., Shin L.M., Lasko N.B., et al. Neurobiological basis for failure to recall extinction memory in posttraumatic stress disorder. Biological Psychiatry 2009 Dec 15, 66(12):1075-1082. Epub 2009 Sep 12. 10.1016/j.biopsych.2009.06.026.
65. Milad M.R., Quinn B.T., Pitman R.K., Orr S.P., Fischl B., Rauch S.L. Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory. Proceedings of the National Academy of Science of the United States of America 2005, 102(30):10706-10711.
66. Milad M.R., Quirk G.J. Fear extinction as a model for translational neuroscience: ten years of progress. Annual Review of Psychology 2012, 63:129-151. 10.1146/annurev.psych.121208.131631.
67. Milad M.R., Quirk G.J., Pitman R.K., Orr S.P., Fischl B., Rauch S.L. Arole for the human dorsal anterior cingulate cortex in fear expression. Biological Psychiatry 2007, 62(10):1191-1194. S0006-3223(07)00401-5 [pii]. 10.1016/j.biopsych.2007.04.032.
68. Milad M.R., Rauch S.L. The role of the orbitofrontal cortex in anxiety disorders. Annals of the New York Academy of Sciences 2007, 1121:546-561.
69. Milad M.R., Rauch S.L., Pitman R.K., Quirk G.J. Fear extinction in rats: Implications for human brain imaging and anxiety disorders. Biological Psychology 2006 Jul, 73(1):61-71. Epub 2006 Feb 13.
70. Milad M.R., Wright C.I., Orr S.P., Pitman R.K., Quirk G.J., Rauch S.L. Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biological Psychiatry 2007, 62(5):446-454.
71. Milad M.R., Zeidan M.A., Contero A., Pitman R.K., Klibanski A., Rauch S.L., et al. The influence of gonadal hormones on conditioned fear extinction in healthy humans. Neuroscience 2010, 168(3):652-658.
72. Norrholm S.D., Jovanovic T., Olin I.W., Sands L.A., Karapanou I., Bradley B., et al. Fear extinction in traumatized civilians with posttraumatic stress disorder: relation to symptom severity. Biological Psychiatry 2011, 69(6):556-563. S0006-3223(10)00949-2 [pii]. 10.1016/j.biopsych.2010.09.013.
73. Orr S.P., Metzger L.J., Lasko N.B., Macklin M.L., Peri T., Pitman R.K. De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder. Journal of Abnormal Psychology 2000, 109(2):290-298.
74. Otto M.W., Tolin D.F., Simon N.M., Pearlson G.D., Basden S., Meunier S.A., et al. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biological Psychiatry 2010, 67(4):365-370. 10.1016/j.biopsych.2009.07.036.
75. Peri T., Ben Shakhar G., Orr S.P., Shalev A.Y. Psychophysiologic assessment of aversive conditioning in posttraumatic stress disorder. Biological Psychiatry 2000, 47(6):512-519.
76. Phelps E.A., Delgado M.R., Nearing K.I., Ledoux J.E. Extinction learning in humans: role of the amygdala and vmPFC. Neuron 2004, 43(6):897-905.
77. Pillay S.S., Gruber S.A., Rogowska J., Simpson N., Yurgelun-Todd D.A. fMRI of fearful facial affect recognition in panic disorder: the cingulate gyrus-amygdala connection. Journal of Affective Disorders 2006, 94(1-3):173-181. S0165-0327(06)00179-0 [pii]. 10.1016/j.jad.2006.04.007.
78. Pitman R.K., Shin L.M., Rauch S.L. Investigating the pathogenesis of posttraumatic stress disorder with neuroimaging. The Journal of Clinical Psychiatry 2001, 62(Suppl.17):47-54.
79. Quirk G.J., Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 2008, 33(1):56-72.
80. Rauch S.L., Whalen P.J., Shin L.M., McInerney S.C., Macklin M.L., Lasko N.B., et al. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biological Psychiatry 2000, 47(9):769-776.
81. Ren J., Li X., Zhang X., Li M., Wang Y., Ma Y. The effects of intra-hippocampal microinfusion of D-cycloserine on fear extinction, and the expression of NMDA receptor subunit NR2B and neurogenesis in the hippocampus in rats. Progress in Neuropsychopharmacology & Biological Psychiatry 2013, 44:257-264. 10.1016/j.pnpbp.2013.02.017.
82. Ressler K.J., Rothbaum B.O., Tannenbaum L., Anderson P., Graap K., Zimand E., et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Archives of General Psychiatry 2004, 61(11):1136-1144. 10.1001/archpsyc.61.11.1136.
83. Rodman A.M., Milad M.R., Deckersbach T., Im J., Chou T., Dougherty D.D. Neuroimaging contributions to novel surgical treatments for intractable obsessive-compulsive disorder. Expert Review of Neurotherapeutics 2012, 12(2):219-227. 10.1586/ern.11.189.
84. Roemer L., Salters K., Raffa S., Orsillo S. Fear and avoidance of internal experiences in GAD: preliminary tests of a conceptual model. Cognitive Therapy and Research 2005, 29(1):71-88. 10.1007/s10608-005-1650-2.
85. Rougemont-Bucking A., Linnman C., Zeffiro T.A., Zeidan M.A., Lebron-Milad K., Rodriguez-Romaguera J., et al. Altered processing of contextual information during fear extinction in PTSD: an fMRI study. CNS Neuroscience and Therapeutics 2011, 17(4):227-236. CNS152 [pii]. 10.1111/j.1755-5949.2010.00152.x.
86. Schweckendiek J., Klucken T., Merz C.J., Tabbert K., Walter B., Ambach W., et al. Weaving the (neuronal) web: fear learning in spider phobia. Neuroimage 2011, 54(1):681-688. S1053-8119(10)01022-0 [pii]. 10.1016/j.neuroimage.2010.07.049.
87. Shin L.M., Davis F.C., Vanelzakker M.B., Dahlgren M.K., Dubois S.J. Neuroimaging predictors of treatment response in anxiety disorders. Biology of Mood & Anxiety Disorders 2013, 3(1):15. 10.1186/2045-5380-3-15.
88. Shin L.M., Orr S.P., Carson M.A., Rauch S.L., Macklin M.L., Lasko N.B., et al. Regional cerebral blood flow in the amygdala and medial prefrontal cortex during traumatic imagery in male and female Vietnam veterans with PTSD. Archives of General Psychiatry 2004, 61(2):168-176.
89. Shin L.M., Wright C.I., Cannistraro P.A., Wedig M.M., McMullin K., Martis B., et al. Afunctional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Archives of General Psychiatry 2005, 62(3):273-281.
90. Smits J.A., Rosenfield D., Davis M.L., Julian K., Handelsman P.R., Otto M.W., et al. Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial. Biological Psychiatry 2014 Jun 1, 75(11):840-846. Epub 2013 Oct 16. 10.1016/j.biopsych.2013.10.008.
91. Smits J.A., Rosenfield D., Otto M.W., Marques L., Davis M.L., Meuret A.E., et al. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions. Journal of Psychiatric Research 2013, 47(10):1455-1461. 10.1016/j.jpsychires.2013.06.020.
92. Smits J.A., Rosenfield D., Otto M.W., Powers M.B., Hofmann S.G., Telch M.J., et al. D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biological Psychiatry 2013, 73(11):1054-1058. 10.1016/j.biopsych.2012.12.009.
93. Storch E.A., Merlo L.J., Bengtson M., Murphy T.K., Lewis M.H., Yang M.C., et al. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. International Clinical Psychopharmacology 2007, 22(4):230-237. 00004850-200707000-00008 [pii]. 10.1097/YIC.0b013e32819f8480.
94. Straube T., Mentzel H.J., Glauer M., Miltner W.H. Brain activation to phobia-related words in phobic subjects. Neuroscience Letters 2004, 372(3):204-208.
95. Tart C.D., Handelsman P.R., Deboer L.B., Rosenfield D., Pollack M.H., Hofmann S.G., et al. Augmentation of exposure therapy with post-session administration of D-cycloserine. Journal of Psychiatric Research 2013, 47(2):168-174. 10.1016/j.jpsychires.2012.09.024.
96. Telch M.J., Bruchey A.K., Rosenfield D., Cobb A.R., Smits J., Pahl S., et al. Effects of Post-Session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia. The American Journal of Psychiatry 2014 Jul 14, 10.1176/appi.ajp.2014.13101407.
97. Tuescher O., Protopopescu X., Pan H., Cloitre M., Butler T., Goldstein M., et al. Differential activity of subgenual cingulate and brainstem in panic disorder and PTSD. Journal of Anxiety Disorders 2011, 25(2):251-257. S0887-6185(10)00192-1 [pii]. 10.1016/j.janxdis.2010.09.010.
98. Tye K.M., Prakash R., Kim S.Y., Fenno L.E., Grosenick L., Zarabi H., et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 2011, 471(7338):358-362. 10.1038/nature09820.
99. Woods A.M., Bouton M.E. D-cycloserine facilitates extinction but does not eliminate renewal of the conditioned emotional response. Behavioral Neuroscience 2006, 120(5):1159-1162. 10.1037/0735-7044.120.5.1159.
100. Zeidan M.A., Igoe S.A., Linnman C., Vitalo A., Levine J.B., Klibanski A., et al. Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats. Biological Psychiatry 2011 Nov 15, 70(10):920-927. Epub 2011 Jul 18. 10.1016/j.biopsych.2011.05.016.